Rigel Pharmaceuticals Inc (RIGL) stock
RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$42.92−0.81 (-1.85%)
Close on Nov 17, 2026Market cap $801.74MP/E 2.7Yield –
Rigel Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Rigel Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was $79.39M, up 20.6% year over year. For fiscal 2025 it was $75.66M, up 140.4% from the year before. The highest annual figure on record is $75.66M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $75.66M | +140.4% |
| FY2024 | Dec 31, 2024 | $31.47M | – |
| FY2023 | Dec 31, 2023 | -$5.74M | – |
| FY2022 | Dec 31, 2022 | -$73.76M | -1354.8% |
| FY2021 | Dec 31, 2021 | $5.88M | – |
| FY2020 | Dec 31, 2020 | -$52.19M | – |
| FY2019 | Dec 31, 2019 | -$41.51M | – |
| FY2018 | Dec 31, 2018 | -$58.83M | – |
| FY2017 | Dec 31, 2017 | -$77.56M | – |
| FY2016 | Dec 31, 2016 | -$75.89M | – |
| FY2015 | Dec 31, 2015 | -$23.41M | – |
| FY2014 | Dec 31, 2014 | -$69.75M | – |
| FY2013 | Dec 31, 2013 | -$86.08M | – |
| FY2012 | Dec 31, 2012 | -$85.21M | – |
| FY2011 | Dec 31, 2011 | -$69.38M | -248.4% |
| FY2010 | Dec 31, 2010 | $46.74M | – |
| FY2009 | Dec 31, 2009 | -$102.78M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $30.65M | +0.4% |
| Q1 FY2026 | Mar 31, 2026 | $2.73M | – |
| Q4 FY2025 | Dec 31, 2025 | $21.98M | +51.6% |
| Q3 FY2025 | Sep 30, 2025 | $24.03M | +10.8% |
| Q2 FY2025 | Jun 30, 2025 | $30.54M | +10011.6% |
| Q1 FY2025 | Mar 31, 2025 | -$893.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $14.50M | – |
| Q3 FY2024 | Sep 30, 2024 | $21.68M | – |
| Q2 FY2024 | Jun 30, 2024 | $302.00K | -94.9% |
| Q1 FY2024 | Mar 31, 2024 | -$5.01M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.24M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.36M | – |
| Q2 FY2023 | Jun 30, 2023 | $5.93M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.07M | – |
| Q4 FY2022 | Dec 31, 2022 | -$21.91M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.30M | – |
| Q2 FY2022 | Jun 30, 2022 | -$12.91M | -123.4% |
| Q1 FY2022 | Mar 31, 2022 | -$25.64M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.09M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.30M | – |
| Q2 FY2021 | Jun 30, 2021 | $55.22M | – |
| Q1 FY2021 | Mar 31, 2021 | -$19.96M | – |
| Q4 FY2020 | Dec 31, 2020 | -$15.57M | – |
| Q3 FY2020 | Sep 30, 2020 | -$19.48M | – |
| Q2 FY2020 | Jun 30, 2020 | -$14.04M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.09M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.65M | -182.9% |
| Q3 FY2019 | Sep 30, 2019 | -$14.64M | – |
| Q2 FY2019 | Jun 30, 2019 | -$16.65M | – |
| Q1 FY2019 | Mar 31, 2019 | -$569.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $11.64M | – |
| Q3 FY2018 | Sep 30, 2018 | -$20.08M | – |
| Q2 FY2018 | Jun 30, 2018 | -$26.99M | – |
| Q1 FY2018 | Mar 31, 2018 | -$23.39M | – |
| Q4 FY2017 | Dec 31, 2017 | -$19.72M | – |
| Q3 FY2017 | Sep 30, 2017 | -$17.61M | – |
| Q2 FY2017 | Jun 30, 2017 | -$19.47M | – |
| Q1 FY2017 | Mar 31, 2017 | -$20.76M | – |
| Q4 FY2016 | Dec 31, 2016 | -$12.46M | – |
| Q3 FY2016 | Sep 30, 2016 | -$22.57M | – |
See a number that looks wrong?